Sharon R Martin, AUD in Lacrosse, WI - Audiologist

Sharon R Martin, AUD is a Audiologist based in Lacrosse, Wisconsin. Sharon R Martin is licensed to practice in Wisconsin (license number 285) and her current practice location is 800 West Ave S, Lacrosse, Wisconsin. She can be reached at her office (for appointments etc.) via phone at (608) 791-9888.

NPI number for Sharon R Martin is 1023077187 and her current mailing address is 700 West Ave S, Attn Physician Services, Lacrosse, Wisconsin. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1023077187.

Contact Information

	Sharon R Martin, AUD
	800 West Ave S, Lacrosse, WI 54601
	(608) 791-9888
	Not Available

Healthcare Provider's Profile

Full Name	Sharon R Martin
Gender	Female
Speciality	Audiologist
Location	800 West Ave S, Lacrosse, Wisconsin
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1023077187
Provider Enumeration Date: 03/18/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for Sharon R Martin such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1023077187	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
231H00000X	Audiologist	285 (Wisconsin)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sharon R Martin is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Sharon R Martin, AUD 700 West Ave S, Attn Physician Services, Lacrosse, WI 54601 Ph: (608) 791-4156	Sharon R Martin, AUD 800 West Ave S, Lacrosse, WI 54601 Ph: (608) 791-9888

News Archive

Idera announces $15 million registered direct offering

Idera Pharmaceuticals today announced that it has received commitments from certain institutional investors to purchase approximately $15 million of securities in a registered direct offering. Idera expects to receive net proceeds of approximately $14.2 million after deducting placement agent fees and other offering expenses.

The AFA to acknowledge use of media in family building, infertility

The American Fertility Association, a 501 (c)(3) national non-profit organization, will recognize the media's role in family building and infertility. Illuminations - an event celebrating the accomplishments of individuals and organizations who have made a positive impact in the fields of reproductive health, family building and fertility - is coming to New York City.

Stand-By Systems now eligible to sell products to federal government

Emerging Healthcare Solutions, Inc. disclosed today that Stand-By Systems has favorably completed their US Government Central Contractor Registration and is now eligible to sell their breakthrough products to the federal government. EHSI has verified the federal eligibility as part of their due diligence related to an option with Stand-By Systems (SBS), owner of the FDA approved SBS 1615 catalytic oxygen generator and associated systems. The option agreement allows EHSI management to perform due diligence prior to finalizing a definitive agreement.

Symposium to cover latest breakthroughs in percutaneous treatment of CAD

The agenda for the Optimizing PCI Outcomes: A Vision for 2012 symposium is now available at: http://www.pcioutcomes.com/conference/agenda.html. This evening symposium will feature the latest clinical and experimental breakthroughs in the percutaneous treatment of coronary artery disease, including the latest clinical data on current and second-generation drug-eluting stent device-based therapies.

Sharon R Martin, AUD - Audiologist in Lacrosse, WI